← SynDRA
VX-702
SynDRA canonical compound SYN0021677 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MAPK14 |
|---|
| Mechanism of action | P38 MAPK inhibitor |
|---|
All known targets
- MAPK14
- MAPK11
- IL1B
- IL6
- MAPK12
- TNF
Mechanisms of action (all sources)
- MAPK14 INHIBITOR
- MAP kinase p38 alpha inhibitor
- MAPK11 INHIBITOR
- MAPK14 MODULATOR
Cross-references
Synonyms
- ST51054128
- I14-1965
- EC-000.2363
- 6-[carbamoyl-(2,6-difluorophenyl)amino]-2-(2,4-difluorophenyl)pyridine-3-carboxamide
- VX702
- UNII-527E7SK68P
- KVK 702
- VX702 cpd
- VX805 cpd
- VX954 cpd
- RefChem:194709
- KVK702
- VX-850
- VX-954
- MFCD11616590
- C19H12F4N4O2
- Kinome_3176
- VX-702, Free Base
- MLS006011165
- orb322883
- SCHEMBL185712
- GTPL6059
- orb1305373
- SCHEMBL29352789
- SCHEMBL29367579
- SCHEMBL29394821
- CHEBI:94489
- EX-A013
- FYSRKRZDBHOFAY-UHFFFAOYSA-N
- GLXC-05171
- HMS3244H04
- HMS3244H08
- HMS3244H12
- HMS3656J20
- HMS3674G05
- EUA54346
- BDBM50314071
- HB1308
Look up VX-702 in the interactive SynDRA portal →